Volume 10, Number 3—March 2004
Babesiosis in Fairfield County, Connecticut
Highlight and copy the desired format.
|EID||Anderson JF, Magnarelli LA. Babesiosis in Fairfield County, Connecticut. Emerg Infect Dis. 2004;10(3):545-546. https://dx.doi.org/10.3201/eid1003.030561|
|AMA||Anderson JF, Magnarelli LA. Babesiosis in Fairfield County, Connecticut. Emerging Infectious Diseases. 2004;10(3):545-546. doi:10.3201/eid1003.030561.|
|APA||Anderson, J. F., & Magnarelli, L. A. (2004). Babesiosis in Fairfield County, Connecticut. Emerging Infectious Diseases, 10(3), 545-546. https://dx.doi.org/10.3201/eid1003.030561.|
To the Editor: Human babesiosis, caused by Babesia microti, was initially described in the eastern United States in 1970 in a woman vacationing on Nantucket Island, Massachusetts (1). With few exceptions, almost all subsequent cases were recorded from islands in the northeastern United States and Cape Cod, Massachusetts (2), until this illness was diagnosed in 13 patients living in New London County in southeastern Connecticut (3,4). B. microti was isolated from white-footed mice, Peromyscus leucopus, captured from 1988 to 1990 in the yards of patients. Babesiosis also was diagnosed in persons living in Wisconsin (5) and in New Jersey (6) who acquired the organism locally. The number of cases of babesiosis reported by health departments on their Web sites and by personal communication in Massachusetts, Rhode Island, and New York State, was 330 from 1988 to 2002, 121 from 1994 to 2002, and 542 from 1986 to 2001, respectively. The number of cases reported by the New York City Health Department from 1991 to 2000 was 75.
From 1991 to 2000, babesiosis was diagnosed in 230 persons residing in New London County and adjacent Middlesex County, Connecticut (7). Fifty-three additional cases were reported in five other counties in Connecticut, but epidemiologic data did not indicate that these infections likely were acquired within Connecticut. We now note a new and distinct geographic focus by reporting the isolation of B. microti from rodents captured in the yards of two patients in whom babesiosis was diagnosed at Greenwich Hospital in 2002. These patients lived in Greenwich, Connecticut, which is located in Fairfield County in the extreme southwestern part of the state. Neither patient had traveled outside of the immediate area of Greenwich, Connecticut, before onset of illness. We also trapped rodents in the yards of two additional patients in whom babesiosis was diagnosed. These two patients had traveled to Rhode Island shortly before becoming ill. Patients became ill from June 23 to July 7, 2002, and none reported a tick bite.
Attempts to trap small mammals on the properties of the four patients were made on July 22, 23, and 29, 2002. Rodents were captured in Sherman box traps baited with peanut butter and apple. Approximately 0.3 mL of blood was drawn from the heart of each animal into a syringe coated with heparin or uncoated. Blood was kept on ice in the field and then returned to the laboratory. A 3- to 5-week-old male Syrian hamster was injected intraperitoneally with 0.1 mL of each blood sample.
Blood smears were obtained from a drop of blood taken from the tail of each hamster on weeks 3 to 6 after injection. Blood cells were stained with Giemsa and examined for B. microti at a magnification of 1,008X. Hamsters were considered uninfected when no parasites were found in 75 fields of stained erythrocytes.
B. microti was isolated from rodents captured at the residences of two of the patients who did not travel outside of the Greenwich area 6 weeks before onset of illness. Blood from two of three white-footed mice and from the two eastern chipmunks, Tamias striatus, captured in the yards of the patients, produced infections in injected hamsters. Infections did not develop in hamsters injected with blood from 10 white-footed mice captured at the residences of two patients who visited Wakefield and Charlestown, Rhode Island, shortly before becoming ill.
B. microti is prevalent in rodent populations in Greenwich, Connecticut, and causes human disease. Establishing evidence of B. microti in rodents and documenting this protozoan parasite as the cause of human disease in Greenwich are important. Relatively high populations of the vector tick, Ixodes scapularis, are present in Greenwich and nearby towns. In 2002, the health departments of Greenwich, Stamford, New Canaan, and Darien submitted 1,671 I. scapularis ticks removed from persons to the Connecticut Agricultural Experiment Station for identification and testing for Borrelia burgdorferi. Two hundred and thirty cases of Lyme disease were reported from these four towns in 2002 (Connecticut Department of Public Health, unpub. data). With such extensive human exposure to ticks and a relatively large number of Lyme disease cases in these four towns and elsewhere in Fairfield County, the number of cases of babesiosis is likely to increase appreciably in the future.
B. microti has been transmitted through blood transfusion in Connecticut (8). Blood collection agencies in southwestern Connecticut and adjacent Westchester County, New York, should be aware of the possibility that blood donors could be infected with this pathogen. Physicians should also be alert to the possibility that patients could be coinfected with the etiologic agents of Lyme disease or human granulocytic ehrlichiosis. Some patients in whom Lyme disease was diagnosed have been simultaneously infected with B. microti (9,10).
We thank Michael Vasil and Bonnie Hamid for their technical assistance; the staff of Greenwich Hospital for assistance; Caroline Baisley and Doug Serafin for helping coordinate the trapping of rodents in Greenwich; and Michael Gosciminski, Palma Caron, and Dennis White for providing documentation of several cases of babesiosis from the states of Rhode Island, Massachusetts, and New York, respectively.
This study was supported in part by Hatch funds administered by the U.S. Department of Agriculture.
- Western KA, Benson GD, Gleason NN, Healy GR, Schultz MG. Babesiosis in a Massachusetts resident. N Engl J Med. 1970;283:854–6.
- Healy G, Ristic M. Human babesiosis. In: Babesiosis of domestic animals and man. Boca Raton (FL): CRC Press, Inc; 1988. p. 209–25.
- Centers for Disease Control and Prevention. Babesiosis—Connecticut. MMWR Morb Mortal Wkly Rep. 1989;38:649–50.
- Anderson JF, Mintz ED, Gadbaw JJ, Magnarelli LA. Babesia microti, human babesiosis, and Borrelia burgdorferi in Connecticut. J Clin Microbiol. 1991;22:36–8.
- Herwaldt BL, Springs FE, Roberts PP, Eberhard ML, Case K, Persing DH, Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg. 1995;▪▪▪:146–51.
- Herwaldt BL, McGovern PC, Gerwel MP, Easton RM, MacGregor RR. Endemic babesiosis in another eastern state: New Jersey. Emerg Infect Dis. 2003;9:184–8.
- Cartter ML, Ertel SH. Lyme disease—Connecticut, 2000, and babesiosis—Connecticut, 1991–2000. Connecticut Epidemiologist Newsletter [serial online] 2001;21:9–12. Available from: http://www.dph.state.ct.us/Publications/BCH/Infectious%20Diseases/ce72001.pdf
- Mintz ED, Anderson JF, Cable RG, Hadler JL. Transfusion-transmitted babesiosis: a case report from a new endemic area. Transfusion. 1991;31:365–8.
- Krause PJ. Babesiosis. In: The medical clinics of North America: tick-borne diseases. Philadelphia: W. B. Saunders Co.; 2002. p. 361–73.
- Grunwaldt E, Barbour AG, Benach JL. Simultaneous occurrence of babesiosis and Lyme disease. N Engl J Med. 1983;308:1166.
Please use the form below to submit correspondence to the authors or contact them at the following address:
John F. Anderson, Connecticut Agricultural Experiment Station, PO Box 1106, New Haven, CT 06504, USA; fax: 203-974-8502
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: February 08, 2011
- Page last updated: February 08, 2011
- Page last reviewed: February 08, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)